Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3666455012 | Product containing pipenzolate and simeticone (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3716244011 | Pipenzolate- and simethicone-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3716245012 | Pipenzolate- and simeticone-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing pipenzolate and simeticone | Is a | Product containing pipenzolate | true | Inferred relationship | Existential restriction modifier | ||
Product containing pipenzolate and simeticone | Has active ingredient | Pipenzolate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing pipenzolate and simeticone | Is a | Product containing simeticone | true | Inferred relationship | Existential restriction modifier | ||
Product containing pipenzolate and simeticone | Has active ingredient | Simeticone | true | Inferred relationship | Existential restriction modifier | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only pipenzolate and simeticone (medicinal product) | Is a | True | Product containing pipenzolate and simeticone | Inferred relationship | Existential restriction modifier | |
Pipenzolate bromide+dimethicone 4mg/40mg/5mL oral suspension | Is a | False | Product containing pipenzolate and simeticone | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets